We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Portola Pharmaceuticals Inc | NASDAQ:PTLA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.03 | 18.00 | 18.10 | 0 | 01:00:00 |
☐
|
Preliminary Proxy Statement
|
|
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
☐
|
Definitive Proxy Statement
|
|
|
x
|
Definitive Additional Materials
|
|
|
☐
|
Soliciting Material under §240.14a-12
|
Portola Pharmaceuticals, Inc.
|
|||
(Name of Registrant as Specified In Its Charter)
|
|||
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|||
Payment of Filing Fee (Check the appropriate box):
|
|||
|
|||
x
|
No fee required.
|
||
|
|||
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
||
|
|||
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
(5)
|
|
Total fee paid:
|
|
|||
☐
|
Fee paid previously with preliminary materials.
|
||
|
|||
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
||
|
|||
|
(1)
|
|
Amount Previously Paid:
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
|
Filing Party:
|
|
(4)
|
|
Date Filed:
|
|
|
|
|
|
•
|
To access the meeting platform, please visit: https://web.lumiagm.com/283341663 beginning at at 8:45 a.m. PT on Friday, June 12, 2020.
|
•
|
In order to attend, vote and ask questions at the Annual Meeting, stockholders must use an 11-digit voter control number and password of ptla2020 to access the virtual meeting.
|
•
|
Stockholders of record can find their 11-digit voter control number on the proxy card or Notice of Internet Availability of Proxy Materials previously received.
|
•
|
Beneficial stockholders who hold their shares through a bank, broker or other nominee must contact their bank, broker or other nominee to request a Legal Proxy and present their Legal Proxy to American Stock Transfer & Trust to obtain an 11-digit voter control number. Requests for registration should be directed to proxy@astfinancial.com or to facsimile number 718-765-8730. Written requests can be mailed to:
|
Investor Contact:
Jennifer Zibuda
Portola Pharmaceuticals
IR@portola.com
|
|
Media Contact:
Emily Faucette
Portola Pharmaceuticals
Media@portola.com
|
1 Year Portola Pharmaceuticals Chart |
1 Month Portola Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions